Cargando…

Role of hsa-miR-105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer

More than 70% of patients with epithelial ovarian cancer (EOC), one of the leading cause of gynecological cancer-related deaths worldwide, are diagnosed at an advanced stage of the disease. Currently, the mainstay for treatment of advanced EOC is tumor debulking surgery followed by combined platinum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mao, Zhang, Shun, Ma, Yuan, Yang, Yang, An, Ruifang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025119/ https://www.ncbi.nlm.nih.gov/pubmed/33846814 http://dx.doi.org/10.3892/or.2021.8035

Ejemplares similares

Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9
por: Kou, Xinxin, et al.
Publicado: (2021)

Hsa-miR-520d Converts Fibroblasts into CD105+ Populations
por: Ishihara, Yoshitaka, et al.
Publicado: (2014)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
por: Huh, J H, et al.
Publicado: (2013)

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
por: Miyamoto, Mayuko, et al.
Publicado: (2020)

Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma
por: Li, Xiao, et al.
Publicado: (2015)

Regulation of Hsa‐miR‐4639‐5p expression and its potential role in the pathogenesis of Parkinson's disease
por: He, Lu, et al.
Publicado: (2023)

circCELSR1 (hsa_circ_0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252
por: Zhang, Shu, et al.
Publicado: (2019)

“Seed-Milarity” Confers to hsa-miR-210 and hsa-miR-147b Similar Functional Activity
por: Bertero, Thomas, et al.
Publicado: (2012)

MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)
por: Petty, Robert D., et al.
Publicado: (2016)

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
por: Tesolato, Sofía Elena, et al.
Publicado: (2023)

Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
por: Tao, Wenhua, et al.
Publicado: (2016)

Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients
por: Eldosoky, Mona A., et al.
Publicado: (2023)

CeRNA network identified hsa-miR-17-5p, hsa-miR-106a-5p and hsa-miR-2355-5p as potential diagnostic biomarkers for tuberculosis
por: Song, Jie, et al.
Publicado: (2023)

Novel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance
por: Moreno-Mateos, Miguel A., et al.
Publicado: (2013)

Hsa-let-7c-5p, hsa-miR-130b-3p, and hsa-miR-142-3p as Novel miRNA Biomarkers for Melanoma Progression
por: Wu, Xuerui, et al.
Publicado: (2022)

hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide
por: HE, JIN-HUA, et al.
Publicado: (2013)

Qualitative and quantitative assessment of sperm miRNAs identifies hsa-miR-9-3p, hsa-miR-30b-5p and hsa-miR-122-5p as potential biomarkers of male infertility and sperm quality
por: Joshi, Meghali, et al.
Publicado: (2022)

The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer
por: Poduval, Deepak, et al.
Publicado: (2020)

hsa-miR-518-5p/hsa-miR-3135b Regulates the REL/SOD2 Pathway in Ischemic Cerebral Infarction
por: Zhao, Boyan, et al.
Publicado: (2022)

Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma
por: Feng, Linxiang, et al.
Publicado: (2023)

Differential expression of Hsa-miR-517a/b in placental tissue may contribute to the pathogenesis of preeclampsia
por: Amin-Beidokhti, Mona, et al.
Publicado: (2021)

miR-873 and miR-105-2 May Affect the Tumour Microenvironment and are Potential Biomarkers for Lung Adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2022)

The Role of hsa-miR-21 and Its Target Genes Involved in Nasopharyngeal Carcinoma
por: Lao, Duc Thuan, et al.
Publicado: (2021)

miR-150 enhances apoptotic and anti-tumor effects of paclitaxel in paclitaxel-resistant ovarian cancer cells by targeting Notch3
por: Kim, Tae Hoen, et al.
Publicado: (2017)

Hypoxia-induced up-regulation of miR-27a promotes paclitaxel resistance in ovarian cancer
por: Feng, Lanlan, et al.
Publicado: (2020)

Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies
por: Chim, Chor Sang, et al.
Publicado: (2011)

miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
por: Li, Hao-Yi, et al.
Publicado: (2017)

Gestational Diabetes Mellitus Regulatory Network Identifies hsa-miR-145-5p and hsa-miR-875-5p as Potential Biomarkers
por: Zamanian Azodi, Mona, et al.
Publicado: (2019)

hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms
por: Chang, XiaoYan, et al.
Publicado: (2017)

Correction: The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer
por: Poduval, Deepak, et al.
Publicado: (2021)

Hsa_circ_0092887 targeting miR‐490‐5p/UBE2T promotes paclitaxel resistance in non‐small cell lung cancer
por: Wang, Limei, et al.
Publicado: (2022)

Implications the Role of miR-155 in the Pathogenesis of Autoimmune Diseases
por: Pashangzadeh, Salar, et al.
Publicado: (2021)

The potential role of hsa_circ_0001079 in androgenetic alopecia via sponging hsa‐miR‐136‐5p
por: Wei, Hanxiao, et al.
Publicado: (2021)

Hsa_circ_0015326 Promotes the Proliferation, Invasion and Migration of Ovarian Cancer Through miR-127-3p/MYB
por: Zhang, Cuiying, et al.
Publicado: (2021)

Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia
por: Rossi, Maura, et al.
Publicado: (2013)

hsa-miR-3177-5p and hsa-miR-3178 Inhibit 5-HT1A Expression by Binding the 3′-UTR Region in vitro
por: Wu, Xue, et al.
Publicado: (2019)

Cancer Cells’ Metabolism Dynamics in Renal Cell Carcinoma Patients’ Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186
por: Morais, Mariana, et al.
Publicado: (2021)

The Highlighted Roles of Metabolic and Cellular Response to Stress Pathways Engaged in Circulating hsa-miR-494-3p and hsa-miR-661 in Alzheimer’s Disease
por: Hojati, Zohreh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dlh59ht1qm1qscq9nub9u081iu